An improved technique for mitosis counting

International Journal of Surgical Pathology

Volumn 13, Issue 2, 2005, Pages 161-165

  Gal, Rivka ^a,b   Rath Wolfson, Lea ^a,b   Rosenblatt, Yevgenia ^a   Halpern, Marisa ^a,b   Schwartz, Ariel ^a,b   Koren, Rumelia ^a,b  

^a HASHARON HOSPITAL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

HPF; Mitosis counting; Mitotic activity index

Indexed keywords

ARTICLE; CANCER GRADING; CELL COUNT; EQUIPMENT DESIGN; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; MICROSCOPE; MITOSIS; MITOSIS INDEX; MUSCLE TUMOR; MYOMETRIUM; OBSERVER VARIATION; PATHOLOGIST; PRIORITY JOURNAL; PROGNOSIS;

FEMALE; HUMANS; LEIOMYOMA; MICROSCOPY; MITOTIC INDEX; OBSERVER VARIATION; PATHOLOGY, SURGICAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; UTERINE NEOPLASMS;

EID: 18144376738     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690501300206     Document Type: Article

References (32)

1. Enzinger FM, Weiss SW. Soft tissue tumors, 3rd ed. Mosby Co., St Louis, pp. 12-14, 1995
2. Silverberg S. Reproducibility of mitosis counts in the diagnosis of smooth muscle tumors of the uterus. Hum Pathol 7:451-454, 1976
3. Anderson MC, Fox H, Tidy JA, Wells M. Female reproductive system. In Symmers WC (ed): Systemic pathology, vol. 6, 3rd ed. Churchil Livingston, Edinburgh, pp. 229-231, 1991
4. Weidner N. The difficult diagnosis in surgical pathology. Uterus and fallopian tubes, WB Saunders Co., Philadelphia, pp. 465-500, 1996
5. Dgani R, Piura B, Ben-Baruch G, Open M, Glezerman M, Nass D, Chzernobilsky B, Yanai-Inbar I, Elchalal U. Clinical-pathological study of uterine leiomyomas with high mitotic activity. Acta Obstet Gynecol Scand 77:74-77, 1998
6. Hendrickson MR, Kempson RL. Pure mesenchymal neoplasms of the uterine corpus. In Hains & Taylor. Obstetrical and gynecological pathology. In Fox H, Wells M (ed): Churchil Livingston Co., New York, pp. 523-549, 1995
7. Silverberg SG, Kurman RJ. Smooth muscle and other mesenchymal tumors. In Rosai J (ed): Atlas of tumor pathology. Tumors of the uterine corpus and gestational trophoblastic disease. (Series 3) AFIP, Washington DC, pp. 130-140, 1991
8. O'Connor DM, Norris HJ. Mitotically active leiomyomas of the uterus. Hum Pathol 21:223-227, 1990
9. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18:535-558, 1994
10. Kempson RL. Editorial: Mitosis counting - II. Hum Pathol 7:482-483, 1976
11. Kempson RL, Hendrickson MR. Pure mesenchymal neoplasms of the uterine corpus: Selected problems. Semin Diagn Pathol 5:172-198, 1988
12. Wheelock JB, Krebs HB, Schneider V, Goplerud DR. Uterine sarcoma: Analysis of prognostic variables in 71 cases. Am J Obstet Gynecol 151:1016-1022, 1985
13. Barter JF, Smith EB, Szpak CA, Hinshaw W, Clarke-Pearson DL, Creasman WT. Leiomyosarcoma of the uterus: Clinicopathologic study of 21 cases. Gynecol Oncol 21:220-227, 1985
14. Taylor HB, Norris HJ. Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 82:40-44, 1966
15. Burns B, Curry RH, Bell ME. Morphologic features of prognostic significance in uterine smooth muscle tumors: A review of eighty-four cases. Am J Obstet Gynecol 135:109-114, 1979
16. Hart WR, Biliam JK Jr. A reassessment of uterine neoplasms originally diagnosed as leiomyosarcomas. Cancer 41:1902-1910, 1978
17. Haapasalo H, Pesonen E, Collan Y. Volume corrected mitotic index (M/V-index). The standard of mitotic activity in neoplasms. Pathol Res Pract 185:551-554, 1989
18. Lipponen PK, Collan Y, Eskelinen MJ. Volume-corrected mitotic index (M/V index) mitotic activity, index (MAI), and histological grading in breast cancer. Int Surg 76:245-249, 1991
19. Laroye GJ, Minkin S. The impact of mitotic index on predicting outcome in breast carcinoma: A comparison of different counting methods in patients with different lymph node status. Mod Pathol 4:456-460, 1991
20. Kronqvist P, Kuopio T, Collan Y. Morphometric grading in breast cancer: Thresholds for mitotic counts. Hum Pathol 29:1462-1468, 1998
21. Lipponen PK, Eskelinen MJ, Collan Y, Marin S, Alhava E. Volume-corrected mitotic index in human pancreatic cancer. Relation to histologic grade, clinical stage, and prognosis. Scand J Gastroenterol 25: 548-554, 1990
22. Lipponen PK, Eskelinen MJ, Collan Y, Peason E, Sotarauta M. Volume-corrected mitotic index (M/V index) in human bladder cancer cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosis. Scand J Urol Nephrol 24:39-45, 1990
23. van Diest PJ, Baak JP, Matze-Cok P, Wisse-Brekelmans EC, van Galen CM, Kurver PH, Bellot SM, Fijnheer J, van Gorp LH, Kwee WS, et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23:603-607, 1992
24. Ellis PS, Whitehead R. Mitosis counting: A need for reappraisal. Hum Pathol 12:3-4, 1981
25. Elder DE, Murphy GF. Melanocytic tumors of the skin. 3rd ed. AFIP, Washington DC, pp. 158-159, 1990
26. Rosai J. Ackerman's surgical pathology, 8th ed. Mosby Co., St Louis, pp.1624-1625, 1998
27. Sadler DW, Coghill SB. Histopathologists, malignancies and undefined high-power fields. Lancet 8: 785-786, 1989
28. Prayson RA, Hart WR. Mitotically active leiomyomas of the uterus. Am J Clin Pathol 97:14-20, 1992
29. Association of Directors of Anatomic and Surgical Pathology. Recommendations for reporting of soft tissue sarcomas. Hum Pathol 30:3-7, 1999
30. Jannink I, van Diest PJ, Baak JP. Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: Classical and random mitotic activity assessment with correction for volume percentage of epithelium. Hum Pathol 26:1086-1092, 1995
31. Norris HJ: Editorial: Mitosis counting. III. Human Pathol 7:483-484, 1976
32. Baak J P. Mitosis counting in tumors. Hum Pathol 21: 683-685, 1990